V

Velocity Clinical Research | Westlake - Los Angeles, CA

Research site

(Unclaimed)

Location

1127 Wilshire Boulevard Suite 805, Los Angeles, California, United States of America

Site insights

Top conditions

Top treatments

K-877-ER

Naltrexone Hydrochloride

Bupropion Hydrochloride

HU6

RGT001-075

CSG452

ALN

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

This study is researching an experimental drug called ALN-PNP (called "study drug"). This is a first in human study. The study drug is not approved b...

Enrolling

Healthy Volunteers

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Drug: Placebo (PB)

Drug: ALN-PNP

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) (INFORMUS)

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Active, not recruiting

Obesity

Drug: Placebo

Drug: Naltrexone-Bupropion (NB) Combination

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

This is a phase 2 randomized, double-blind, placebo-controlled parallel group study of 3 dose levels of HU6 in subjects with nonalcoholic steatohepat...

Active, not recruiting

Fatty Liver

Nonalcoholic Steatohepatitis

Drug: HU6

Other: Placebo